share_log

Ainos and Tah-An Sign MoU To Explore Manufacture Of VELDONA Animal Investigational New Drug

Benzinga Real-time News ·  Jan 23, 2023 07:12

Ainos advances commercialization of its VELDONA low-dose interferon treatment through strategic partnerships

Ainos intends to begin clinical trials into VELDONA's potential veterinary applications in the first quarter of 2023

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment